The Startup’s Dilemma: Planning for Success vs. Conserving Cash
By Andrew Levitch
Having spent the past 12 years as a Life Sciences and Technology CFO consulting to venture and private-equity backed companies, I have seen a consistent and recurring dilemma faced by these emerging companies: the struggle between planning for success and conserving cash. The age-old adage “you have to spend money…Read More
Read MoreIs Now a Good Time to Be Planning For An IPO?
By Nancy Hargreaves
As we zero-in on year-end 2023, the IPO market appears to be opening up a little. While there is cautious optimism around this emerging trend, it’s clear that the volume of transactions and valuations seen in 2020 and 2021 are unlikely to be seen again any time soon. Today, pent-up…Read More
Read MoreA Mentor’s Advice for CFOs: How to Help Clients Navigate Their Way to Success
By Jonathan Wolter
In my 45+ year career, I have been fortunate to be CFO at a number of technology and life science companies ranging in size from early stage to those with mature operations, private and public, including SmartRent, PARC, Vera Therapeutics, Amyris, Soleno Therapeutics, and Kyverna Therapeutics, among others. Over the…Read More
Read MoreAdvice for Life Sciences Companies Going Commercial for the First Time
By Jim Mackaness
Life sciences companies going commercial for the first time have the opportunity to create significant shareholder value – but the path to achieving this milestone will likely be volatile. The words that best sum up my advice to management teams and boards at life sciences companies that embark on the…Read More
Read More